1 document found, page 1 of 1

Sort by Issue Date
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

Use and management of Trastuzumab Deruxtecan in people with breast cancer: reco...

Amorim, Ana Paula; Chemela, Ana Raquel; Cordeiro, Rita; Freitas, Jorge; Góis, Carlos; Lamas, Bárbara; Núñez, Vanesa; Pedro, Susana; Ponte, Sandra

Trastuzumab Deruxtecan is indicated for the treatment of Human Epidermal growth factor Receptor-type 2 HER2-positive or HER2-low breast cancer, showing favorable efficacy and safety profiles. However, it can lead to some severe adverse events, such as interstitial lung disease. We performed four regional experience sharing sessions and one final national discussion session, with the participation of several nur...

Date: 2024   |   Origin: Onco.News
More info.
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

1 Results

Queried text

Refine Results

Author










Date


Document Type


Access rights


Resource


Subject